Literature DB >> 16815359

Evolution of hypertensive disease: a revolution in guidelines.

Bryan Williams1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16815359     DOI： 10.1016/S0140-6736(06)68943-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 2.  Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis.

Authors:  Thomas A Gaziano; Lionel H Opie; Milton C Weinstein
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

Review 3.  Systolic hypertension: an increasing clinical challenge in Asia.

Authors:  Jeong Bae Park; Kazuomi Kario; Ji-Guang Wang
Journal:  Hypertens Res       Date:  2014-12-11       Impact factor: 3.872

4.  Interactions between the adducin 2 gene and antihypertensive drug therapies in determining blood pressure in people with hypertension.

Authors:  Sharon L R Kardia; Yan V Sun; Sara C Hamon; Ruth Ann Barkley; Eric Boerwinkle; Stephen T Turner
Journal:  BMC Med Genet       Date:  2007-09-13       Impact factor: 2.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.